Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol Myers Squibb presents Gal-3 inhibitors

Nov. 29, 2021

Takeda Pharmaceutical identifies new 5-HT4 receptor agonists

Nov. 29, 2021

Merck & Co. synthesizes new LAAO inhibitors

Nov. 29, 2021

U.S. researchers patent TREM2 agonists

Nov. 29, 2021

Eli Lilly divulges new MRGPRX1 agonists

Nov. 29, 2021

Polycystic ovary syndrome murine model reveals CYP17 involvement

Nov. 26, 2021

ALD-2510 selectively depletes tumor-infiltrating Tregs for activity in vivo

Nov. 26, 2021

Osteoclasts modified with tetracycline show efficacy in models of heterotopic ossification

Nov. 26, 2021

Compounds targeting NPC1 protein show promising antiviral activity against SARS-CoV-2

Nov. 26, 2021

SHP-1 abundance determines the responsiveness of an individual NK cell

Nov. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...